Business Context and Reporting Period
This Form 8-K Current Report was filed by MiMedx Group, Inc. on April 22, 2013. The report addresses a corporate event regarding the listing of the Company's common stock.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing event and does not contain financial statement data.
Material Changes
The primary material event reported is the approval by The NASDAQ Capital Market of the Company's application to list its common stock. Trading under the symbol "MDXG" became effective at the beginning of trading on April 25, 2013.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, risk factors, contingencies, or unusual items. It serves solely to disclose the stock listing approval and incorporates a press release as Exhibit 99.1.
Investor Verification Checklist
- Verify the commencement of trading under the new symbol "MDXG" on April 25, 2013.
- Review the attached press release (Exhibit 99.1) for additional context on the listing.
- Confirm the Company's continued compliance with NASDAQ Capital Market listing standards.